This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2359
Title
Diminished Protective Response to ROS leads to Coagulation
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|---|---|
Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation | adjacent | Moderate | Not Specified | Shihori Tanabe (send email) | Under development: Not open for comment. Do not cite | Under Development |
Taxonomic Applicability
Term | Scientific Term | Evidence | Link |
---|---|---|---|
human | Homo sapiens | Moderate | NCBI |
Sex Applicability
Sex | Evidence |
---|---|
Unspecific | Moderate |
Life Stage Applicability
Term | Evidence |
---|---|
All life stages | Moderate |
Key Event Relationship Description
ROS are oxygen-derived molecules that oxidize molecules or are converted into oxygen radicals (André-Lévigne D, et al., 2017). ROS have dual-effects which are cell damaging or beneficial roles (André-Lévigne D, et al., 2017, Beckman KB and Ames BN, 1998, Bedard K and KH Krause, 2007). ROS generated by NOX2, a NADPH oxidase, in macrophage play an important role in killing of phagocytosed microorganisms (Bedard K and KH Krause, 2007). The ROS accumulation cause mitochondrial dysfunction which leads to coagulopathy associated with inflammatory signaling pathways (Saleh J et al., 2020). Polymorphonuclear leucocytes, commonly referred to as neutrophils, generate large amounts of ROS via the NADPH oxidase complex (Barrett CD et al., 2018).
Evidence Collection Strategy
The references were searched with terms "ROS" and "coagulation" in NCBI database. The references that have relevant insights in diminished protective response to ROS and coagulation were selected and cited.
Microsoft co-pilot was used to write the relationship between NRF2 inactivation and blood coagulation (as of January 19th, 2024).
Evidence Supporting this KER
Biological Plausibility
The ROS released from the polymorphonuclear leucocytes following trauma and haemorrhagic shock led to lung injury and coagulopathy (Barrett CD et al., 2018). Serpin family A member 1 (SERPINA1/alpha-1-antitrypsin), a serine protease inhibitor, inhibits coagulation factor 2a (thrombin) (Cohen AB., 1973). SERPINA1 is a member of low-density lipoprotein (LDL) and involved in ROS network (Lubrano V, and Balzan S. 2020). ROS are required for release of granzyme B (GzmB), a cytotoxic lymphocyte protease, into the cytosol (Mangan MS et al., 2016). SERPINA1 is converted into a ROS-sensitive granzyme B (GzmB) inhibitor by replacing the P4-P3’ reactive center loop residues (Mangan MS et al., 2016). Thrombin activates NADPH oxidase and produces ROS, which leads to fibroblast proliferation (Zhou SY et al., 2010). Endothelial exposure of thrombin induces NOX-dependent superoxide superoxide anion and hydrogen peroxide (Pai WY et al., 2017, Holland JA et al., 1998).
Empirical Evidence
The presence of ROS assists in the transformation of a circulating, non-oxidized, circular-shaped beta2-glycoprotein 1 into an oxidized J-shape, which binds to antiphospholipid antibodies such as anticardiolipin, lupus anticoagulant, and anti-beta2-GP1 antibodies (Janardhan et al., 2020). Domain V of beta2gP1 binds with the phospholipid layer of platelets or endothelial cells via Annexin (Janardhan et al., 2020).
Nrf2, a basic leucine zipper transcription factor, plays a crucial role in cellular defense against oxidative stress by inducing the expression of cytoprotective and detoxifying genes. Activation of Nrf2 has protective roles against cancer onset and progression, while persistent activation can lead to malignant progression, chemo/radio resistance, and poor prognosis Pouremamali, F., et al. (2022).
Nrf2’s involvement in inflammatory responses and erythrocyte homeostasis suggests a potential impact on blood coagulation. Additionally, the interaction between Nrf2 and NF-κB, and the increase in inflammatory factors due to Nrf2 deficiency, highlight the complex role of Nrf2 in cellular processes (Motohashi et al., 2021).
Keap1, a major regulator of Nrf2, ubiquitinates Nrf2 under basal conditions, targeting it for proteasomal degradation in the cytoplasm. This regulation is crucial for maintaining cellular homeostasis and responding to oxidative stress (Khodakarami et al., 2022).
Uncertainties and Inconsistencies
Considering the effect of Nrf2 inactivation on blood coagulation, it is hypothesized that inactivation could lead to increased inflammatory responses, potentially promoting blood coagulation. However, this relationship requires further research for confirmation.
Known modulating factors
Modulating Factor (MF) | MF Specification | Effect(s) on the KER | Reference(s) |
---|---|---|---|
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Fibrin may induce oxidative stress.
Domain of Applicability
This KER is applied for human.
References
André-Lévigne D, Modarressi A, Pepper MS, Cuenod BP. (2017) Reactive Oxygen Species and NOX Enzymes Are Emerging as Key Players in Cutaneous Wound Repair. Int J Mol Sci. 18(10):2149.
Barrett CD et al., (2018) Blood clotting and traumatic injury with shock mediates complement-dependent neutrophil priming for extracellular ROS, ROS-dependent organ injury and coagulopathy. Clin Exp Immunol. 194(1):103-117.
Beckman KB, BN Ames. (1998) The free radical theory of aging matures. Physiol Rev. 78(2):547-81.
Bedard K, KH Krause. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 87(1):245-313.
Cohen AB. (1973) Mechanism of action of alpha-1-antitrypsin. J Biol Chem. 248(20):7055-9.
Holland JA, Meyer JW, Donnell RW, Johnson DK, Ziegler LM. (1998) Thrombin Stimulated Reactive Oxygen Species Production in Cultured Human Endothelial Cells. Endothelium. 6(2):113-121.
Janardhan, V., V. Janardhan and V. Kalousek. (2020) COVID-19 as a Blood Clotting Disorder Masquerading as a Respiratory Illness: A Cerebrovascular Perspective and Therapeutic Implications for Stroke Thrombectomy. Journal of Neuroimaging 30(5): 555-561.
Khodakarami A. (2022) The molecular biology and therapeutic potential of Nrf2 in leukemia. Cancer Cell International. 22:241.
Lubrano V, S Balzan. (2020) Role of oxidative stress-related biomarkers in heart failure: galectin 3, α1-antitrypsin and LOX-1: new therapeutic perspective? Mol Cell Biochem. 464(1-2):143-152.
Mangan MS, Bird HS, Kaiserman D, Matthews AY, Hitchen C, et al. (2016) A Novel Serpin Regulatory Mechanism: SerpinB9 is reversibly inhibited by vicinal disulfide bond formation in the reactive center loop. J Biol Chem. 291(7):3626-38.
Motohashi H. (2021) NRF2によるストレス応答と硫黄代謝制御. Journal of Japanese Biochemical Society 93(5): 674-683 .
Pai WY, Lo WY, Hsu T, Peng CT, Wang Hj. (2017) Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation. Front Physiol. 8:994.
Pouremamali F, et al. (2022) An update of Nrf2 activators and inhibitors in cancer prevention/promotion. Cell Communication and Signaling, 20, Article number: 100.
Saleh J, Peyssonaux, Singh KK, Edeas M. (2020) Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 54:1-7.
Zhou SY, Xiao W, Pan XJ, Zhu MX, Yang ZH, et al. (2010) Thrombin promotes human lung fibroblasts to proliferate via NADPH oxidase/reactive oxygen species/extracellular regulated kinase signaling pathway. Chin Med J (Engl). 123(17):2432-9.